U.S., May 5 -- ClinicalTrials.gov registry received information related to the study (NCT07564947) titled 'Impact of Ganoderma Lucidum on NRF2 Levels and Antioxidant Status in Metabolic Asscociated Fatty Liver Disease (GL-MAFLD-NRF2 Study)' on April 27.
Brief Summary: This RCT investigates the impact of Ganoderma lucidum on antioxidant staus, NRF2 levels and lipid metabolism in individuals with Metabolic Associated Fatty Liver Disease.
Study Start Date: April 28
Study Type: INTERVENTIONAL
Condition:
MAFLD
Fatty Liver
Fatty Liver, Non-alcoholic Fatty Liver Disease, NAFLD
Fatty Liver, Nonalcoholic
Fatty Liver Disease
Oxidative Stress
Inflammation
Intervention:
DIETARY_SUPPLEMENT: Starch Placebo
Intervention will invovle the the intake...